$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in INTERCEPT PHARMACEUTICALS, INC. for free.

CIK Number: 0001270073
IRS Number: 223868459
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ICPT
Company Address: 10 HUDSON YARDS, 37TH FLOOR NEW YORK 10001
Phone number: 646-747-1000
Former name: INTERCEPT PHARMACEUTICALS INC, date of change: 2003-11-13

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.

Market Capitalization: $2.80B
Prev close: $113.57
Average Daily Volume: 475,158
Days Low: $110.70
Year Low: $89.76
Year High: $177.93

INTERCEPT PHARMACEUTICALS, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
AKKARAJU SRINIVASDirector403,68845,846,846shares bought: 438,110 / shares sold: -23,438 STRONG BUYAug 30 201924 days ago
Bright LisaPresident, International20,4522,322,734shares bought: 24,753 / shares sold: -20,903 BUYJul 03 20193 months ago
Cawkwell GailSVP, Med Affairs, Safety & PV18,9612,153,401shares bought: 5,850 / shares sold: -1,914 STRONG BUYAug 14 20191 month ago
Durso Jerome BenedictChief Operating Officer32,6893,712,490shares bought: 38,000 / shares sold: -4,092 STRONG BUYAug 27 201927 days ago
Ford David AChief Human Resources Officer11,5461,311,279shares bought: 14,100 / shares sold: -2,131 STRONG BUYSep 18 20195 days ago
Kapadia SandipCFO and Treasurer26,6933,031,524shares bought: 33,400 / shares sold: -5,589 STRONG BUYJul 03 20193 months ago
Kim Richard JPresident US Comm & Strat Mktg17,0141,932,280shares bought: 9,800 / shares sold: -3,476 STRONG BUYJul 15 20192 months ago
Pruzanski MarkPresident & CEO470,67353,454,333shares bought: 188,311 / shares sold: -153,091 BUYJul 03 20193 months ago
Sullivan Ryan TGeneral Counsel and Secretary26,4293,001,542shares bought: 29,800 / shares sold: -3,371 STRONG BUYAug 14 20191 month ago
Weyer ChristianEVP, Research & Development18,3012,078,445shares bought: 22,800 / shares sold: -4,641 STRONG BUYAug 29 201925 days ago

View all INTERCEPT PHARMACEUTICALS, INC. insiders.

INTERCEPT PHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 18 2019ICPTINTERCEPT PHARMACE ...Ford David AChief Human Resourc ...SellS70.0080056,00011,54612.3 K to 11.5 K (-6.48 %)
Aug 30 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP60.325,207314,086403,688398.5 K to 403.7 K (+1.31 %)
Aug 29 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF60.5035721,59918,30118.7 K to 18.3 K (-1.91 %)
Aug 29 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF60.5035721,59918,30118.7 K to 18.3 K (-1.91 %)
Aug 27 2019ICPTINTERCEPT PHARMACE ...Durso Jerome BenedictChief Operating Off ...Payment of ExerciseF60.9031919,42732,68933 K to 32.7 K (-0.97 %)
Aug 22 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA64.301,18075,874398,481397.3 K to 398.5 K (+0.30 %)
Aug 22 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA67.1229,0001,946,480397,301368.3 K to 397.3 K (+7.87 %)
Aug 22 2019ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorGrantA65.8537,6042,476,223368,301330.7 K to 368.3 K (+11.37 %)
Aug 14 2019ICPTINTERCEPT PHARMACE ...Sullivan Ryan TGeneral Counsel and ...Payment of ExerciseF66.0368945,49526,42927.1 K to 26.4 K (-2.54 %)
Aug 14 2019ICPTINTERCEPT PHARMACE ...Cawkwell GailSVP, Med Affairs, S ...Payment of ExerciseF65.8931921,01918,96119.3 K to 19 K (-1.65 %)
Aug 09 2019ICPTINTERCEPT PHARMACE ...Ford David AChief Human Resourc ...Payment of ExerciseF66.051288,45412,34612.5 K to 12.3 K (-1.03 %)
Jul 15 2019ICPTINTERCEPT PHARMACE ...Kim Richard JPresident US Comm & ...Payment of ExerciseF69.711117,73817,01417.1 K to 17 K (-0.65 %)
Jul 03 2019ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF79.17463,64218,65818.7 K to 18.7 K (-0.25 %)
Jul 03 2019ICPTINTERCEPT PHARMACE ...Kapadia SandipCFO and TreasurerPayment of ExerciseF79.1761548,69026,69327.3 K to 26.7 K (-2.25 %)
Jul 03 2019ICPTINTERCEPT PHARMACE ...Ford David AChief Human Resourc ...Payment of ExerciseF79.17927,28412,47412.6 K to 12.5 K (-0.73 %)

View all INTERCEPT PHARMACEUTICALS, INC. insider transactions.